Brain Implant Trial Group Publishes 13-Category Guidelines for Participant Autonomy

The BCI Pioneers Coalition released a set of trial guidelines on Tuesday, drawn from the experiences of people who have participated in brain-computer interface studies. The group was co-founded in 2022 by Ian Burkhart, the first person to use a brain implant for hand control in a clinical trial. The guidelines are aimed at academic labs, clinicians and companies developing BCIs, and they treat participants as contributors with ongoing rights rather than as temporary research subjects.

The guidelines contain recommendations in 13 categories, including recognition, compensation, privacy and the handling of brain data. Burkhart’s own trials involved a 96-electrode array implanted in his movement-control region, followed by two years-long studies over a seven-and-a-half-year period. He says he attended the lab two or three days a week for four-hour sessions, making the commitment comparable to part-time work. Jennifer Chandler, a University of Ottawa law and neuroethics professor, says participants invest time, body and intellectual effort.

The guidelines reflect a shift in how invasive neurotechnology is discussed: from technical capability to governance of long-term human-machine relationships. Existing clinical ethics rules cover consent and risk, but BCI participants can remain connected to research teams for years while producing sensitive neural data. The coalition’s recommendations push researchers to prepare participants for media attention, acknowledge their role in scientific outputs, and consider whether coauthorship or public recognition is appropriate when participants shape the technology.

The stakes are concrete for people with severe paralysis who depend on BCIs for communication, movement and independence. The guidelines do not bind companies or regulators, but they provide participants a shared framework for negotiating compensation, authorship, privacy and non-disclosure terms around neural data. They also address media exposure and the difficulty of concealing participants’ identities when a breakthrough becomes public.